摘要
自身免疫性甲状腺炎(Autoimmune thyroiditis,AIT)是一种自身免疫性疾病,包括桥本甲状腺炎(Hashimoto’s thyroiditis,HT)、弥漫性毒性甲状腺肿(Toxic diffuse goiter)等,以桥本甲状腺炎者居多。刘铜华教授认为情志内伤及先天禀赋不足是AIT发病的关键因素,肝郁气滞火热是本病的关键病机,在临床治疗中重视疏肝理气类和清热泻火解毒类药物的使用,重视“火”类病机,重视“虚实”辨证以及心理疏导,常以自拟的甲炎康泰方为底方,辨证加减论治。本文就刘铜华教授应用甲炎康泰方化裁治疗AIT的临床经验和体会进行论述,以期指导AIT的中医治疗。
The autoimmune thyroiditis(AIT)is an autoimmune disease,including Hashimoto's thyroiditis(HT),toxic diffuse goiter,etc.Hashimoto's thyroiditis is the majority.Professor Liu Tonghua believes that emotional internal injury and lack of innate endowment are the key factors in the onset of AIT,and liver stagnation and heat stagnation are the key pathogenesis of the disease.In clinical treatment,attention should be paid to the use of drugs for soothing liver and qi and clearing heat and fire and detoxification,the pathogenesis of"fire",the differentiation of"deficiency and deficiency"and psychological guidance,and self-designed Jiyankang Tai prescription is often used as the base prescription for syndrome differentiation and treatment.This article discusses the clinical experience and experience of Professor Liu Tonghua in treating AIT with Kangtai prescription of hypothyroidism,in order to guide the TCM treatment of AIT.
作者
马知遥
陈源
宁洲俊
秦灵灵
吴丽丽
刘铜华
MA Zhiyao;CHEN Yuan;NING Zhoujun;QIN Lingling;WU Lili;LIU Tonghua(The Second Clinical Medical School of Beijing University of Chinese Medicine,Beijing 100078,China;Science and Technology Department,Beijing University of Chinese Medicine,Beijing 100029,China;Key Laboratory of Health Cultivation of the Ministry of Education,Beijing University of Chinese Medicine,Beijing 100029,China)
出处
《世界科学技术-中医药现代化》
CSCD
北大核心
2024年第2期517-522,共6页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
兵团科学技术局(外专局)、科协重大科技项目计划(2020AA005):兵团重大专项:新疆特色代谢性疾病道地药、民族药的创新研究与开发,负责人:刘铜华。
关键词
自身免疫性甲状腺炎
瘿病
桥本甲状腺炎
名医经验
Autoimmune thyroiditis
Gall disease.Hashimoto's thyroiditis
Doctors experience
